Substance Withdrawal Syndrome: all 74 studies

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Dexmedetomidine for Invasive Ventilation In the NEOnateNot yet recruitingNCT07493785Phase 2/3
• Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)RecruitingNCT06675539
• Kratom Use Disorder Management Using Clonidine and/or BuprenorphineRecruitingNCT05883358
• Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3RecruitingNCT05834478Phase 3
• Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco UseNot yet recruitingNCT05512091
• Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' DiseaseRecruitingNCT05461820Phase 4
• Novel Use of Probenecid to Alleviate Symptoms of Opioid WithdrawalRecruitingNCT04939623Phase 2
• Varenicline OTC Trial on Efficacy and SafetyCompletedNCT03557294Phase 4Results posted
• Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill AdultsCompletedNCT03435614Results posted
• Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence SyndromeCompletedNCT02801331Not applicableResults posted
• Utility of Olanzapine in the Treatment of Opioid Withdrawal in the EDCompletedNCT02643355Not applicableResults posted
• Nicotine Patch for Marijuana WithdrawalCompletedNCT01400243Phase 4Results posted
• Nicotine Replacement Therapy in the Intensive Care UnitCompletedNCT01362959Phase 4Results posted
• Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent PatientsTerminatedNCT01100437Phase 4Results posted
• Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in SmokersCompletedNCT01048944Phase 4Results posted
• Efficacy of Extended Release Tramadol for Treating Prescription Opioid WithdrawalCompletedNCT00980044Phase 2/3Results posted
• Effect of Ondansetron for Withdrawal SymptomsCompletedNCT00695864Not applicableResults posted
• Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis WithdrawalCompletedNCT00480441Phase 2Results posted
• Efficacy of XYZ for Withdrawal SyndromeCompletedNCT07543809Not applicable
• Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB PatientsCompletedNCT06029634
• Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.Status unknownNCT05485519Phase 3
• Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19CompletedNCT05336656
• The Effect of Honey on Lessening the Withdrawal SymptomsStatus unknownNCT05264428Not applicable
• Neurostimulation to Improve NOWS OutcomesActive, not recruitingNCT05129020Not applicable
• Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use DisorderCompletedNCT05053503Not applicable
• EA for PAAS: A pRCTStatus unknownNCT04917185Not applicable
• Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use DisorderStatus unknownNCT04850664Phase 2
• Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid WithdrawalCompletedNCT04731935Not applicable
• AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)CompletedNCT04422808
• Qualitative Understanding of Experiences With the SIMPLIFY TrialCompletedNCT04320381
• Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid LeukemiaActive, not recruitingNCT04147533Phase 2
• Opioid Tapering After Spine SurgeryCompletedNCT04140955Not applicable
• Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid WithdrawalCompletedNCT04075214Not applicable
• Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.CompletedNCT03996096
• Serum HBV RNA Value on Chronic Hepatitis B Virus Infection ManageCompletedNCT03909191
• Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)TerminatedNCT03645603Phase 2
• Early Rehabilitation in Critically Ill Children - The PICU Liber8 StudyCompletedNCT03573479
• Opioid Withdrawal Symptoms in Critically Ill PatientsCompletedNCT03374722
• High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics OpioidCompletedNCT03156907Phase 2
• Substance Use Disorders and Tobacco HabitsStatus unknownNCT03118011Not applicable
• Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in CerebrosesCompletedNCT03114904Not applicable
• Protocolized Sedative Weaning VS. Usual Care in Pediatric Critically Ill, RCTCompletedNCT03018977Not applicable
• Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care TreatmentCompletedNCT02952846Not applicable
• Abuse and Addiction in ICUStatus unknownNCT02951793
• Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?CompletedNCT02825459Not applicable
• Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose ReductionCompletedNCT02801357Phase 1
• Process Evaluation Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal in ENTCompletedNCT02782156
• Physiology and Therapeutic Management of Neonatal Abstinence SyndromeCompletedNCT02768844Not applicable
• Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential InstitutionsCompletedNCT02715440Not applicable
• The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment ProgramCompletedNCT02431728Phase 1/2
• A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained SubjectsCompletedNCT02391571Phase 3
• Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort StudyCompletedNCT02318290
• Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot StudyStatus unknownNCT02249026Phase 1/2
• Electronic Cigarettes in Daily Dependent SmokersCompletedNCT02108626Phase 4
• The Potentially Addictive Properties of Soda: A Feasibility StudyCompletedNCT02044757Not applicable
• Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts.CompletedNCT01949571Phase 2
• Medications Development for the Treatment of Cannabis Related DisordersCompletedNCT01204723Phase 1
• Naloxone Methadone Combination (NAMEKO)WithdrawnNCT01160432Not applicable
• Nicotine Patch Trial in Syrian Primary Care SettingsCompletedNCT01085032Phase 2
• Opiate Detoxification Using the Combined Hemoperfusion-hemodialysisStatus unknownNCT01021566Phase 3
• Therapeutic Massage to Manage Withdrawal Related AnxietyCompletedNCT00992979Phase 2
• The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male SmokersCompletedNCT00900900Phase 2
• Validation of a Pediatric-Specific Abstinence Syndrome Assessment ToolWithdrawnNCT00792415
• The Effect of Valproate on Benzodiazepine Withdrawal SeverityCompletedNCT00570219Not applicable
• Treatment of Polydrug-Using Opiate Dependents During WithdrawalCompletedNCT00367874Phase 4
• Lofexidine for Inpatient Opiate DetoxCompletedNCT00235729Phase 3
• Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal SyndromeCompletedNCT00146471Phase 3
• Long-Term Lamivudine Therapy for Chronic Hepatitis BCompletedNCT00120354Phase 4
• Lithium Cannabis Withdrawal StudyCompletedNCT00114439Phase 2
• Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1CompletedNCT00032968Phase 3
• Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1CompletedNCT00032955Phase 3
• A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)CompletedNCT00001008Not applicable
• Acute Withdrawal From Smoked Cocaine - 9CompletedNCT00000292Phase 1
• Effects of Dynorphin 1-13 on Heroin Addiction - 1CompletedNCT00000244Phase 2

← Substance Withdrawal Syndrome overview